Edition:
United Kingdom

London Market Report Headlines

European shares edge down with all eyes on the Fed

Bourses opened slightly lower across Europe on Tuesday as traders awaited clues from the Federal Reserve on its plans to move towards unwinding its $4.2 trillion portfolio of Treasuries and mortgage-backed securities.

UK Stocks-Factors to watch on Sept 19

Britain's FTSE 100 index is seen opening 7 points higher at 7,260.4 on Tuesday, according to financial bookmakers. * RBS: European Union regulators approved a British plan allowing bailed-out Royal Bank of Scotland to support smaller alternative banks with funds totalling around 835 million pounds ($1.1 billion) to encourage competition. * RYANAIR: Ryanair Chief Executive Michael O'Leary said he was sure a series of flight cancellations would not help future

UK Stocks-Factors to watch on Sept 18

Britain's FTSE 100 index is seen opening up 21 points at 7,236.1 on Monday, according to financial bookmakers. * SHELL: Royal Dutch Shell Plc began restarting its 325,700-barrel-per-day (bpd) joint-venture Deer Park, Texas, refinery on Sunday for the first time since it was shut three weeks ago by Tropical Storm Harvey, said sources familiar with plant operations. * BAE SYSTEMS: Qatar's defence minister has signed a letter of intent to purchase 24 Typhoon jet

UK Stocks-Factors to watch on Sept 15

Britain's FTSE 100 index is seen opening 8 points lower on Friday, according to financial bookmakers. * ROYAL BANK OF SCOTLAND: Britain's markets watchdog has rejected calls to publish a report into allegations Royal Bank of Scotland bankrupted small companies to pick up their assets on the cheap, saying it would instead release a detailed summary soon. * ROYAL DUTCH SHELL: Royal Dutch Shell Plc may begin resuming production at its 325,700-barrel-per-day (bp

UK Stocks-Factors to watch on Sept 14

Britain's FTSE 100 index is expected to open 6 points higher at 7,385 on Thursday, according to financial bookmakers. * GLAXOSMITHKLINE: A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline's shingles vaccine warrants approval for its use in adults aged 50 and over. * LONDON STOCK EXCHANGE: London Stock Exchange Group (LSE) has agreed to buy an additional stake of up to 6.8 percent in its